Lupin Limited — Cefpodoxime Exporter Profile
Indian Pharmaceutical Exporter · #3 for Cefpodoxime · $10.6M export value · DGFT Verified
Lupin Limited is the #3 Indian exporter of Cefpodoxime with $10.6M in export value and 297 verified shipments. Lupin Limited holds a 13.3% market share in Cefpodoxime exports across 9 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
Lupin Limited — Cefpodoxime Export Profile: Buyers & Destinations
Where Does Lupin Limited Export Cefpodoxime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $2.6M | 81 | 29.7% |
| MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF | $2.1M | 97 | 24.5% |
| GERMANY | $1.1M | 32 | 12.7% |
| SOUTH AFRICA | $1.0M | 29 | 12.0% |
| GREECE | $882.9K | 23 | 10.3% |
| MACEDONIA | $704.1K | 28 | 8.2% |
| COLOMBIA | $81.9K | 2 | 1.0% |
| MACEDONIATHE FORMER YUGOSLAV REPUBLIC OF | $78.4K | 3 | 0.9% |
| MACEDONIA THE FORMER YUGOSLAV REPUBLIC OF | $68.5K | 2 | 0.8% |
Lupin Limited exports Cefpodoxime to 9 countries. The largest destination is FRANCE accounting for 29.7% of Lupin Limited's Cefpodoxime shipments, followed by MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF (24.5%) and GERMANY (12.7%). These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefpodoxime from Lupin Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ALKALOID AD SKOPJE | MACEDONIA | $1.9M | 68 |
| CENTRE SPECIALITIES PHARMACEUTIQUES | FRANCE | $945.5K | 34 |
| CSPM | FRANCE | $787.2K | 21 |
| MERCKLE GMBH | GERMANY | $670.5K | 22 |
| ALKALOID AD | MACEDONIA | $464.6K | 21 |
| ALKALOID AD SKOPJE-FARMACIJA, | MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF | $425.2K | 22 |
| ALKALOID AD SKOPJEFARMACIJA, | MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF | $378.7K | 15 |
| MERCKLE GMBH NGER | GERMANY | $377.4K | 8 |
| ALKALOID AD SKOPJE-FARMACIJA | MACEDONIA | $273.3K | 8 |
| UPD LEA GLEN PHARMA DYNAMICS | SOUTH AFRICA | $269.0K | 6 |
Lupin Limited supplies Cefpodoxime to 30 buyers globally. The largest buyer is ALKALOID AD SKOPJE (MACEDONIA), followed by CENTRE SPECIALITIES PHARMACEUTIQUES (FRANCE) and CSPM (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefpodoxime Export Value and How Much Does Lupin Limited Contribute?
India exported $33.7M worth of Cefpodoxime through 1,734 shipments from 178 suppliers to 78 countries, serving 442 buyers globally. Lupin Limited contributes $10.6M to this total, accounting for 13.3% of India's Cefpodoxime exports. Lupin Limited ships Cefpodoxime to 9 countries through 30 buyers.
What Is the Average Shipment Value for Lupin Limited's Cefpodoxime Exports?
Lupin Limited's average Cefpodoxime shipment value is $35.7K per consignment, based on 297 shipments totaling $10.6M. The largest destination is FRANCE (29.7% of Lupin Limited's Cefpodoxime exports).
How Does Lupin Limited Compare to Other Indian Cefpodoxime Exporters?
Lupin Limited ranks #3 among 178 Indian Cefpodoxime exporters with a 13.3% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.9M), LUPIN LIMITED ($10.6M), AUROBINDO PHARMA LIMITED ($4.5M). Lupin Limited processed 297 shipments to 9 destination countries.
What Cefpodoxime Formulations Does Lupin Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CEFPO. PROX.SUS.40MG/5ML-100ML-BIOGARAN Cefpodoxime Proxetil Oral Suspension Others-Cephalosporin | $213.9K | 5 |
| PHARMA CEFPOD PROX TABLETS 100MG FRANCE BIOGARAN CEFPODOXIME PROXETIL 100MG 1BOXx10 TABS OTHERS CEPHALOSPORIN | $200.0K | 4 |
| CEFPO. PROX.SUS.40MG/5ML-100ML-BIOGARANCEFPODOXIME PROXETIL ORAL SUSPENSION OTHERS-CEPHALOSPORINNOS | $181.8K | 7 |
| CEFPOD PROX.TABS 100MG-FRANCE-TEVA CEFPODOXIME PROXETIL TABLETS 100MG OTHERS-CEPHALOSPORIN | $177.5K | 6 |
| CEFPO. PROX.SUS.40MG/5ML-100ML-BIOGARAN CEFPODOXIME PROXETIL ORAL SUSPENSION OTHERS- CEPHALOSPORIN | $169.1K | 4 |
| CEFPO PROX SUS 40MG 5ML 100ML BIOGARAN Cefpodoxime Proxetil Oral Suspension Others Cephalosporin | $168.7K | 4 |
| CEFPOD PROX.TABS 100MG-FRANCE-BIOGARAN Cefpodoxime Proxetil Tablets 100mg Others-Cephalosporin | $164.0K | 4 |
| DOXCEF 200MG TABLETS ALKALOID RUSSIA (CEFPODOXIME PROXETIL 200MG) - 1BOX x 10 TABS | $150.0K | 3 |
| FOREXO(CEFPODOXIME)SUSP 8MG/ML - RO Cefpodoxime Proxetil oral suspension 40mg/5ml Others-Cephalosporin | $150.0K | 3 |
| TRIDOX 200MG - 10'S SERBIA Cefpodoxime Proxetil tablets | $150.0K | 3 |
Lupin Limited exports 175 distinct Cefpodoxime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CEFPO. PROX.SUS.40MG/5ML-100ML-BIOGARAN Cefpodoxime Proxetil with 5 shipments worth $213.9K.
Regulatory Requirements: Exporting Cefpodoxime to Key Markets
What Lupin Limited must comply with to export Cefpodoxime to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Lupin Limited Compare to Nearest Cefpodoxime Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AUROBINDO PHARMA LTD | $10.9M | 219 | 13 | $50.0K |
| 3 | LUPIN LIMITED ★ | $10.6M | 297 | 9 | $35.7K |
| 4 | AUROBINDO PHARMA LIMITED | $4.5M | 89 | 10 | $50.0K |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.6M | 32 | 4 | $50.0K |
Lupin Limited ranks #3 among 178 Indian Cefpodoxime exporters. Average shipment value of $35.7K compared to the market average of $189.3K. The closest competitors by value are AUROBINDO PHARMA LTD and AUROBINDO PHARMA LIMITED.
Which Indian Ports Ship Cefpodoxime Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 174 | 10.0% |
| SAHAR AIR | 166 | 9.6% |
| JNPT/ NHAVA SHEVA SEA | 133 | 7.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 128 | 7.4% |
| JNPT | 88 | 5.1% |
| DELHI AIR | 81 | 4.7% |
| HYDERABAD ICD | 79 | 4.6% |
| DELHI AIR CARGO ACC (INDEL4) | 78 | 4.5% |
What Other Advanced Antibiotics Products Does Lupin Limited Export?
Lupin Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Lupin Limited's Cefpodoxime Exports
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Lupin Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
About Lupin Limited
Lupin Limited exports 38 products worth $271.4M. Beyond Cefpodoxime, top products include Isoniazid, Cephalexin, Simvastatin, Rifampicin, Amlodipine. View the complete Lupin Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefpodoxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefpodoxime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lupin Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 297 individual customs records matching Lupin Limited exporting Cefpodoxime, covering 175 formulations to 9 countries via 30 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 78+ countries, 442+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefpodoxime Export Data from Lupin Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Cefpodoxime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
Cefpodoxime Stats
Company Overview
Top Products by Lupin Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefpodoxime. For current shipment-level data, contact TransData Nexus.